Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Granville Baird Capital Partners was a prominent European private equity firm that specialized in mid-market buyouts and growth capital investments. The firm maintained a significant focus on the healthcare and life sciences sectors, investing in medical technology, diagnostics, and healthcare services across the United Kingdom and Continental Europe. Formed through the integration of the UK-based Granville and the European private equity operations of Robert W. Baird & Co., the firm provided strategic guidance and capital to scaling companies. In 2008, the Granville Baird brand was retired as the entity was fully integrated and rebranded as Baird Capital. The firm was known for its hands-on operational approach and its ability to facilitate international expansion for its portfolio companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Granville Baird Capital Partners.